Product Launch Announcement: Palboheal 125 (Palbociclib 125mg) Capsule
We are proud to introduce Palboheal 125, a premium formulation of Palbociclib 125mg capsules, developed to provide advanced targeted therapy in hormone receptor-positive breast cancer. Designed to support improved progression control, Palboheal 125 reflects our commitment to delivering innovative and reliable oncology solutions.
🔍 Product Overview
Generic Name: Palbociclib
Strength: 125mg
Formulation: Capsule
Primary Indications:
Palboheal 125 – Palbociclib 125mg capsule is indicated for:
- Hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer
- First-line treatment in combination with an aromatase inhibitor
- In combination with fulvestrant in patients with disease progression following endocrine therapy
Mechanism of Action:
Palboheal 125 contains Palbociclib 125mg capsule, a selective CDK4/6 inhibitor. It works by inhibiting cyclin-dependent kinases 4 and 6, which are critical in cell cycle progression. By blocking these enzymes, Palbociclib prevents cancer cells from progressing from the G1 phase to the S phase, thereby slowing tumor growth and proliferation.
💡 Key Benefits
- Targeted CDK4/6 inhibition
- Proven efficacy in combination therapy
- Delays disease progression
- Oral administration for patient convenience
- Established global treatment approach
🎯 Target Audience
- Medical oncologists
- Oncology hospitals & cancer specialty clinics
- Healthcare providers managing advanced breast cancer
- Institutions offering targeted combination therapy
🏥 Commitment to Clinical Excellence
Palboheal 125-Palbociclib 125mg Capsule is manufactured in compliance with stringent quality standards and regulatory guidelines. We are dedicated to delivering safe, effective, and high-quality oncology products that support improved patient outcomes.
📦 Availability
Palboheal 125-Palbociclib 125mg Capsule are available through authorized distributors and healthcare supply channels. For supply inquiries, bulk orders, or regulatory documentation, please contact our sales or distribution team.
Palboheal 125 – Advancing HR+ Breast Cancer Care.
